Dr. Denise A. Valenti is the founder and President of IMMAD, LLC – Impairment Measurement and Marijuana.  The company provides services, consulting, and development of technology for the responsible use of cannabis. She has over three decades of experience in working with patients having sensory impairment, cognitive dysfunction, vision, and age-related changes as well as the driving experience.  Dr. Valenti has been committed to the elimination of medical inequities throughout her career and was awarded the American Public Health Association’s Vision Care Outstanding Student Award for her efforts in aging. Dr. Valenti’s clinical residency emphasized driving and adaptive technologies for driving. Their lab pioneered the use of bioptic head mounted miniature telescopes for use to obtain restricted driver’s licenses. She developed rehabilitation strategies to identify and modify ocular motility deficits; primarily nystagmus, that had the retinal and neural plasticity to achieve gains in optotype acuity with intense rehabilitation.  Dr. Valenti received NIH funding to investigate the use of Optical Coherence Tomography in Alzheimer’s disease and later researched visual field technologies that at the time were novel, using temporal striped targets that have variable contrast. Work in Parkinson’s was funded through Fight For SIght and included the study of retinal response. She had unfunded work in Parkinson’s investigating cornea response, abnormal blink, lacrimal response, and olfactory dysfunction. She has provided direct clinical care with the Indian Health Services and ran a clinic for the indigent in inner city Detroit, MI. Her residency was in Houston, Texas where she provided house calls/homecare in the communities suffering greatest health disparity.  Dr. Valenti has served as a consultant to General Motors on aging and sensory impairments and driving. Dr. Valenti currently studies retinal response with recent marijuana use and is developing a technology for use by roadside by law enforcement. Dr. Valenti is currently a certified Social Equity candidate for research license. The credential is provided by the Massachusetts Cannabis Control Commission.